Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
01/25/2017 Cameron Durrant
Lead Independent Director 500,000 Acquisition 0
01/25/2017 Elliot M. Maza
Independent Director 500,000 Acquisition 0
01/25/2017 Jeffrey Paley
Director 500,000 Acquisition 0
01/25/2017 Daniel Kazado
Director 500,000 Acquisition 0
01/25/2017 John A. Neczesny
Independent Director 500,000 Acquisition 0
01/04/2017 Daniel Kazado
Director 76,503 Buy at $0.186 per share.
Any news on reverse split or appeal for compliance.
Nano cap Immune Pharmaceuticals (NASDAQ:IMNP) perks up 6% premarket on robust volume in response to its announcement that it has entered into an exclusive sub-license agreement with a French Technology Transfer Office called SATT Sud-Est to develop, manufacture and commercialize mono- and bispecific antibodies in oncology. The antibodies target components of the tumor microenvironment and angiogenic factors.
• The research will be conducted under the responsibility of Inserm, the National Center for Scientific Research (CNRS), the University of Cote d'Azur (UCA), the Scientific Center of Monaco (CSM) and the company.
• The research project is based on a technology for producing tetravalent IgG-1-like bispecific antibodies developed by Immune scientific co-founder Dr. Jean Kadouche. The antibodies will target vascular endothelial growth factor (VEGF) and cytokines of interleukin 8 (IL-8).
Why the green today and yesterday
Tons of volume today maybe some insiders buying up some stock ?
Someone buying up a pile of stock
You think it's going to reverse split
I have seen it on web in Swedish just a rumor don't take with a grain of salt
11am est
I only ask because I got my proxy vote in mail and there voting dec 15
Well is the reverse split coming they vote dec 15th
Who is buying this garbage it don't going to do anything
Rslavick@icloud.com
I own about the same you watching any other stocks I was watching (pvct) but was undecided
How many shares you own
You really think this stock will be worth 10x what it is now ?
The 10-Q is not much to shout about, you have to agree, and, naturally enough, ACTL's supporters aren't paying too much attention to it. They are focusing instead on the share structure and it must be said that, as far as the figures in the SEC filings are concerned, ACTL does look better than the majority of its OTC counterparts in that respect. On September 10, for example, there were just 10.2 million shares issued and outstanding which, considering the share price, isn't that much.
There was also quite a lot of toxic debt, though. Plenty of convertible notes saw the light of day between October 2014 and June 2015 and the company still seems to be borrowing money under these agreements. As always, the notes in question can be turned into common stock at discounts that, in this particular case, range from 35% to 42%. This seems to be causing a problem.
The fact that in a matter of three days investors traded more than 20 million shares suggest that the O/S count might have grown over the last few weeks. The number of authorized shares was increased recently from 75 million to 750 million which might also serve as a hint at potential dilution in the near future.
Unfortunately, the reason for all this is... meaningless hype. Despite the fact that the company hasn't put out any significant filings or press releases lately, people roaming the message boards and social networks seem to be extremely excited about the future. Capital letters and exclamation marks have been excessively abused over the last few days and even some of the promotional newsletters like Aim High Profits are also touting the ticker. Compensations haven't been disclosed.
Predictably, neither the people with the capital letters, nor the pump outfits say anything about the financials. As always, we'll take care of that instead of them. Here's what ACTL had at the end of July:
cash: $7,193
total assets: $9,967
current liabilities: $190,746
quarterly revenues: $61,224
quarterly net loss: $151,609
Timothy Honeycutt
Won't fill my order for 5 mill at .0001